Veterinary Medicines

Salmoporc, lyophilisate and solvent for suspension for injection / lyophilisate for use in drinking water

Authorised
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 421/125 (histidine-adenine auxotrohic), Live
Download as PDF

Product identification

Medicine name:
SALMOPORC LIOFILIZADO Y DISOLVENTE PARA SUSPENSION INYECTABLE / LIOFILIZADO PARA ADMINISTRACION EN AGUA DE BEBIDA
Salmoporc, lyophilisate and solvent for suspension for injection / lyophilisate for use in drinking water
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 421/125 (histidine-adenine auxotrohic), Live
Target species:
  • Pig (suckling piglet)
  • Pig (sow for reproduction)
  • Pig
Route of administration:
  • Oral use
  • Subcutaneous use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, strain 421/125 (histidine-adenine auxotrohic), Live
    500000000.00
    Colony forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Oral use
    • Pig (suckling piglet)
      • Meat and offal
        6
        week
  • Subcutaneous use
    • Pig (sow for reproduction)
      • Meat and offal
        6
        week
    • Pig
      • Meat and offal
        6
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AE02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • (ID2) 200 Dose: Box (Cardboard) with 1 Bottle (Glass) with 200 Dose
  • (ID1) 20 Dose; 20 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 20 millilitre(s) and 1 Bottle (Glass) with 20 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Salud Animal S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
  • IDT Biologika GmbH
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 4027 ESP
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0290/001
Concerned member states:
  • France
  • Spain

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2024
Download

Combined File of all Documents

English (PDF)
Published on: 25/09/2025
Download